Redeye states that the Q1 report came in above our estimates on both sales and adjusted EBITDA, with...
Redeye comments on Transtema’s Q1 report, showing strong organic growth in Sweden but a relatively s...
Sales +9% and EBIT +14% vs. ABGSCe Expect cons. to raise '25e-'27e sales by ~3-4% USD/SEK movements ...
Sales 2% higher than expected; 24% y-o-y FX adjusted But higher investments increased lead to miss o...
Redeye comments on Nekkar’s Q1 report that missed our expectations, mainly driven by a lower revenue...
Redeye comments on Truecaller’s Q1 2025 report, which was somewhat softer than expected.
Redeye noted that BeammWave's Q1 2025 report significantly exceeded expectations, primarily due to r...
Redeye updates on Invisio following weaker than expected Q1-results.
Orders +4%, sales -9%, adj. EBITA -22% vs. our estimates EBITA miss driven by 3 high-volume delivery...
Redeye comments on BrightBid’s Q1 report, with numbers aligning with the preliminary figures.
Redeye comments on the announcement of SEK13.6m loan, a directed issue of warrants and a SEK10.
Redeye provides an in-depth take on AroCell’s Q1 report.
Suominen's Q1 was fairly in line with Vara Research consensus, while the company also announced a la...
Redeye strengthens its positive view of Avensia following a strong Q1 report, showing high growth an...
Preliminary Q1 figures: sales -17% y-o-y, -13% vs. ABGSCe Weak market and client phase-outs, but sur...
Surprisingly high costs, but solid top-line and customer intake We cut '25e EBITA by 7%, but raise '...
Cost reduction initiatives in DE and NL short-term Focus on margin improvement journey and selective...
Problemen i Storbritannien och uppskalningen av organisationen tynger resultaten tillfälligt, men an...
We hosted the new CEO Magnus Lönn this morning Strategy to replicate the Nordic & Baltics success to...
Redeye comments on Avensia’s Q1 report, beating our expectations significantly on both sales and EBI...
